2014-11 | JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells | 서혜명 |
2015-09 | Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression | 서혜명 |
2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation | 서혜명 |
2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase3 and histone deacetylation. | 서혜명 |
2015-09 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase | 서혜명 |
2013-08 | LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25 | 서혜명 |
2021-09 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice | 서혜명 |
2021-05 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2G2019S Parkinson's Disease Model Mice | 서혜명 |
2014-07 | miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling | 서혜명 |
2016-01 | MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons | 서혜명 |
2021-03 | Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model | 서혜명 |
2023-09 | Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy | 서혜명 |
2016-05 | Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model | 서혜명 |
2018-05 | Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson's Disease. | 서혜명 |
2018-05 | Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson's Disease | 서혜명 |
2020-05 | Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease | 서혜명 |
2012-07 | Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease | 서혜명 |
2014-08 | Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology | 서혜명 |
2007-02 | Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells | 서혜명 |
2015-06 | Reduction of Nfia gene expression and subsequent target genes by binge alcohol in the fetal brain | 서혜명 |
2007-11 | Regulation of functional phenotypes of cord blood-derived eosinophils gamma-secretase inhibitor | 서혜명 |
2007-11 | Regulation of Functional Phenotypes of Cord-blood-derived Eosinophils by gamma-secretase inhibitor | 서혜명 |
2007-04 | SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-γ-stimulated BV2 microglial cells through a composite nuclear factor-κB/PU.1 binding site | 서혜명 |
2007-04 | SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-gamma-stimulated BV2 microglial cells through a composite nuclear factor-kappa B/PU.1 binding site | 서혜명 |
2009-04 | SCAMP5 Links Endoplasmic Reticulum Stress to the Accumulation of Expanded Polyglutamine Protein Aggregates via Endocytosis Inhibition | 서혜명 |
2017-11 | Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide | 서혜명 |
2014-04 | Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain | 서혜명 |
2010-09 | The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome | 서혜명 |
2010-02 | Transformation to formalized business process model | 서혜명 |
2004-12 | Ts65Dn 다운신드롬 모델 생쥐에서 프로테아좀 활성의 노화 의존적 변화 | 서혜명 |